Microbot Medical Timeline

Events

• 2026-06-30 - Production Milestone - Microbot Medical adds Sanmina manufacturing capacity for LIBERTY - Microbot framed the Sanmina agreement as a second manufacturing site and capacity expansion. LIBERTY is an FDA-cleared, single-use robotic system for remote endovascular procedures. - source: globenewswire.com
• 2026-06-23 - Market Signal - Microbot Medical expands LIBERTY commercial footprint to seven Eastern U.S. states - Microbot said the system spans multiple hospitals and specialty centers serving Pennsylvania and New Jersey. The company said LIBERTY now has accounts across seven Eastern U.S. states. - source: globenewswire.com
• 2026-06-09 - Market Signal - Microbot Medical adds first Michigan LIBERTY healthcare-system customer - Microbot Medical announced the first Michigan healthcare-system adoption of its LIBERTY endovascular robotic system. The company described the customer as one of Michigan’s largest healthcare systems. The adoption followed North Carolina expansion and… - source: ir.microbotmedical.com
• 2026-06-02 - Market Signal - Microbot Medical secures first North Carolina LIBERTY customer - The company said the account broadened LIBERTY penetration across the Southeast, Mid-Atlantic and Northeast U.S. The customer was described as a leading academic center with a multi-hospital network. - source: ir.microbotmedical.com
• 2026-05-26 - Regulatory - Microbot Medical receives first international LIBERTY marketing approval - Israel became the second jurisdiction, after the U.S., to clear LIBERTY for marketing. The AMAR approval supports commercialization in Israel and a Free Sale Certificate for additional submissions. The approval supports Microbot Medical's path toward fielded… - source: ir.microbotmedical.com
• 2026-05-05 - Market Signal - Microbot Medical reports multiple LIBERTY account wins after full release - The company said new accounts included two ACCESS-PVI pivotal clinical trial sites. The announcement framed commercial adoption as validation of LIBERTY in everyday practice. - source: ir.microbotmedical.com
• 2025-11-05 - Product Launch - Microbot Medical starts U.S. limited market release for LIBERTY - LIBERTY became commercially available in the U.S. through selected high-procedure-volume regions. The company said the launch followed commercial-team hiring and a third-party logistics partnership. The product gives The company a concrete offering for… - source: ir.microbotmedical.com
• 2025-09-16 - Market Signal - Microbot Medical closes $25.2 million preferred-option exercise tranche - The first closing generated approximately USD 25,200,000 in gross proceeds. The transaction involved exercise of outstanding preferred investment options. Microbot Medical completed the first closing of preferred investment-option exercises for approximately… - source: globenewswire.com
• 2025-09-08 - Regulatory - Microbot Medical receives FDA clearance for LIBERTY endovascular robot - Microbot Medical received FDA 510(k) clearance for the LIBERTY endovascular robotic system. The clearance moved LIBERTY from development into a regulated commercial pathway for endovascular procedures. The event anchors Microbot as a surgical robotics pure… - source: ir.microbotmedical.com